Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Tandem Diabetes Care (NQ: TNDM )

30.81 +0.07 (+0.23%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Tandem Diabetes Care

< Previous 1 2
...
5 6 7 8 9 10 11 12 Next >
Tandem Diabetes Pressured As Control-IQ Trials Combined; Raymond James Downgrades TNDM
Tandem Diabetes Care (NASDAQ: TNDM) remained under pressure on Monday, after the company accounted for plans of a combined analysis of three tri 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 24, 2023
Via Benzinga
Tandem Diabetes Care to Present at the BofA Securities 2023 Health Care Conference
From Tandem Diabetes Care, Inc.
Via Business Wire
2 Beaten-Down Growth Stocks to Buy in April
These companies have lucrative opportunities ahead. 
Via The Motley Fool
Where Tandem Diabetes Care Stands With Analysts
Via Benzinga
Tandem Diabetes Care Announces Control-IQ Technology Meta-analysis Demonstrating Positive Clinical Impact of Automatic Correction Bolusing on Glucose Control in People with Type 1 Diabetes
From Tandem Diabetes Care, Inc.
Via Business Wire
Tandem Diabetes Care to Announce First Quarter 2023 Financial Results on May 3, 2023
From Tandem Diabetes Care, Inc.
Via Business Wire
Tandem Diabetes Care Announces NEJM Publication of Study Demonstrating Increased Time in Range in Young Children with Type 1 Diabetes Using the t:slim X2 Insulin Pump with Control-IQ Technology
From Tandem Diabetes Care, Inc.
Via Business Wire
2 Growth Stocks to Buy While They Are Still Down
Don't wait too long before loading up on these stocks. 
Via The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For March 29, 2023
Via Benzinga
This Stock Could Soar By as Much as 106%, According to Wall Street
Some of Wall Street's predictions seem a bit aggressive, but investors should still consider this company. 
Via The Motley Fool
Tandem Diabetes Care Shares Fell Post Q4 Results; Guides Within Estimates
Via Benzinga
Tandem Diabetes Acquires Swiss Based Insulin Patch Pump Developer
Via Benzinga
Buy These 2 Beaten-Growth Stocks Before They Soar
You'll thank me down the road. 
Via The Motley Fool
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
Tandem Diabetes Care Appoints New Chair of Board of Directors
From Tandem Diabetes Care, Inc.
Via Business Wire
Tandem Diabetes Care Announces Fourth Quarter 2022 Financial Results and Full Year 2023 Financial Guidance
From Tandem Diabetes Care, Inc.
Via Business Wire
Tandem Diabetes Care Announces Upcoming Conference Presentations
From Tandem Diabetes Care, Inc.
Via Business Wire
Earnings Scheduled For February 22, 2023
Companies Reporting Before The Bell • Rio Tinto (NYSE:RIO) is projected to report earnings for its Fiscal Year 2022. 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 26, 2023
Via Benzinga
Tandem Diabetes Care Completes Acquisition of Insulin Patch Pump Developer, AMF Medical
From Tandem Diabetes Care, Inc.
Via Business Wire
Tandem Diabetes Care to Announce Fourth Quarter and Full Year 2022 Financial Results on February 22, 2023
From Tandem Diabetes Care, Inc.
Via Business Wire
CommVault Systems, Halozyme Therapeutics And Other Big Stocks Moving Lower On Wednesday
U.S. stocks traded higher, with the Dow Jones gaining around 80 points on Wednesday. Here are some big stocks recording losses in today’s session. 
Via Benzinga
Tandem Diabetes Care Reports Preliminary, Unaudited 2022 Sales and Reaffirms 2023 Outlook
From Tandem Diabetes Care, Inc.
Via Business Wire
Tandem Diabetes Care to Present at the 41st Annual J.P. Morgan Healthcare Conference
From Tandem Diabetes Care, Inc.
Via Business Wire
2 Stocks Down 72% or More to Buy in 2023 and Hold for 10 Years
These companies' shareholders will have the last laugh. 
Via The Motley Fool
Tandem Diabetes Care to Acquire Insulin Patch Pump Developer, AMF Medical
From Tandem Diabetes Care, Inc.
Via Business Wire
Tandem Diabetes Care Earns Great Place to Work Certification™
From Tandem Diabetes Care, Inc.
Via Business Wire
Tandem Diabetes Care Study Demonstrates Improvements of All Clinical Endpoints in Adults with Type 2 Diabetes Using Control-IQ Technology
From Tandem Diabetes Care, Inc.
Via Business Wire
Tandem Diabetes Care Announces Upcoming Conference Presentation
From Tandem Diabetes Care, Inc.
Via Business Wire
< Previous 1 2
...
5 6 7 8 9 10 11 12 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.